|
"陳培哲"的相關文件
顯示項目 176-200 / 526 (共22頁)
<< < 3 4 5 6 7 8 9 10 11 12 > >>
每頁顯示[10|25|50]項目
| 國立臺灣大學 |
2012 |
Serum interleukin 6 level correlates with outcomes of acute exacerbation of chronic hepatitis B
|
Pan, Corinna Jen-Hui; Wu, Hui-Lin; Kuo, Stephanie Fang-Tzu; Kao, Jia-Horng; Tseng, Tai-Chung; Liu, Chen-Hua; Chen, Pei-Jer; Liu, Chun-Jen; Chen, Ding-Shinn; 陳定信; 劉振驊; 高嘉宏; 劉俊人; 陳培哲 |
| 國立臺灣大學 |
2012 |
Androgen pathway stimulates MicroRNA-216a transcription to suppress the tumor suppressor in lung cancer-1 gene in early hepatocarcinogenesis
|
Chen, Po-Jen; Yeh, Shiou-Hwei; Liu, Wan-Hsin; Lin, Chen-Ching; Huang, Hsuan-Cheng; Chen, Chi-Ling; Chen, Ding-Shinn; Chen, Pei-Jer; 陳定信; 葉秀慧; 陳培哲; 陳祈玲 |
| 國立臺灣大學 |
2012 |
Young Chronic Hepatitis B Patients With Nucleos(t)ide Analogue-induced Hepatitis B e Antigen Seroconversion Have a Higher Risk of HBV Reactivation
|
Tseng, Tai-Chung; Liu, Chun-Jen; Su, Tung-Hung; Yang, Hung-Chih; Wang, Chia-Chi; Chen, Chi-Ling; Kuo, Stephanie Fang-Tzu; Liu, Chen-Hua; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 劉俊人; 陳培哲 |
| 國立臺灣大學 |
2012 |
Long-Term Effectiveness of Ribavirin Plus Pegylated Interferon Combination Therapy for Hepatitis C Patients in Taiwan: A Population-Based Study
|
Chu, Yu-Tseng; Chen, Pei-Jer; Liu, Chun-Jen; Kuo, Raymond N. C.; Yeh, Yi-Chun; Lai, Mei-Shu; 賴美淑; 劉俊人; 陳培哲 |
| 國立臺灣大學 |
2012 |
Emerging hepatitis B virus infection in vaccinated populations: a rising concern?
|
Su, Tung-Hung; Chen, Pei-Jer; 蘇東弘; 陳培哲 |
| 國立臺灣大學 |
2012 |
Activation of tyrosine phosphatase SHP-1 determines the apoptotic effect of sorafenib on HCC cells.
|
Tai, W-T.; Shiau, C-W.; Cheng, A-L.; Chen, P-J.; Chen, K-F.; 陳昆鋒; 陳培哲 |
| 國立臺灣大學 |
2012 |
SUSTAINED HCV CLEARANCE AND INCREASED HBSAG SEROCLEARANCE IN PATIENTS WITH DUAL CHRONIC HEPATITIS C AND B POST-PEGINTERFERON ALFA-2A AND RIBAVIRIN TREATMENT: A 5-YEAR FOLLOW-UP
|
Liu, C. -J.; Chuang, W. -L.; Lee, C. -M.; Yu, M. -L.; Lu, S. -N.; Wu, S. -S.; Liao, L. -Y.; Chen, C. -L.; Kuo, H. -T.; Chao, Y. -C.; Tung, S. -Y.; Yang, S. -S.; Kao, J. -H.; Liu, C. -H.; Su, W. -W.; Lin, C. -L.; Chen, P. -J.; Chen, D. -S.; 陳定信; 劉振驊; 高嘉宏; 劉俊人; 陳培哲; 陳祈玲 |
| 國立臺灣大學 |
2012 |
Novel sorafenib derivatives (SC-40, SC-43 and SC-60) show better anti-tumor effects than sorafenib in hepatocellular carcinoma through SHP-1/STAT3-mediated signaling pathway
|
Tai, Wei-Tien; Shiau, Chung-Wai; Cheng, Ann-Lii; Chen, Pel-Jer; Chen, Kuen-Feng; 鄭安理; 陳昆鋒; 陳培哲 |
| 國立臺灣大學 |
2012 |
Hepatitis B Virus Nucleocapsid but Not Free Core Antigen Controls Viral Clearance in Mice
|
Lin, Yi-Jiun; Wu, Hui-Lin; Chen, Ding-Shinn; Chen, Pei-Jer; 陳培哲 |
| 國立臺灣大學 |
2012 |
PD-1 blockage reverses immune dysfunction and hepatitis B viral persistence in a mouse animal model
|
Tzeng, HorngTay; Chen, PeiJer; Hsu, PingNing; 陳培哲; 許秉寧 |
| 國立臺灣大學 |
2012 |
Profiles and Clinical Significance of HBsAg Titer in Patients Receiving Peginterferon Alfa-2a plus Ribavirin for the Treatment of Dual Chronic Infection with Hepatitis B and C Viruses
|
Liu, Chun-Jen; Yu, Ming-Lung; Lee, Chuan-Mo; Chen, Chi-Ling; Chuang, Wan-Long; Wu, Shun-Sheng; Yang, Sien-Sing; Kao, Jia-Horng; Lin, Chih-Lin; Chen, Pei-Jer; Chen, Ding-Shinn; 陳定信; 高嘉宏; 劉俊人; 陳培哲; 陳祈玲 |
| 國立臺灣大學 |
2012 |
Blockade of STAT3 activation by sorafenib derivatives through enhancing SHP-1 phosphatase activity
|
Chen, Kuen-Feng; Tai, Wei-Tien; Hsu, Cheng-Yi; Huang, Jui-Wen; Liu, Chun-Yu; Chen, Pei-Jer; Kim, InKi; Shiau, Chung-Wai; 陳昆鋒; 陳培哲 |
| 國立臺灣大學 |
2012 |
Dynamic changes of precore and basal core promoter mutations in HBeAg-positive chronic hepatitis B patients receiving interferon therapy
|
Yang, Hung-Chih; Chen, Chi-Ling; Shen, Yueh-Chi; Peng, Cheng-Yuan; Liu, Chun-Jen; Tseng, Tai-Chung; Su, Tung-Hung; Chuang, Wan-Long; Yu, Ming-Lung; Dai, Chia-Yen; Liu, Chen-Hua; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; 陳定信; 劉振驊; 高嘉宏; 蘇東弘; 劉俊人; 陳培哲; 陳祈玲 |
| 國立臺灣大學 |
2012 |
HBeAg(+) and sex ratio of offspring: Evidence form Taiwan's three million newborns
|
Lin, Ming-Jen; Chen, Pei-Jer; Luoh, Ming-Ching; 陳培哲 |
| 國立臺灣大學 |
2012 |
Peginterferon alfa-2a plus Low Dose Ribavirin versus Peginterferon alfa-2a Monotherapy for Dialysis Patients with Hepatitis C Virus Genotype 1 Infection: A Randomized Trial
|
Liu, Chen-Hua; Liang, Cheng-Chao; Su, Tung-Hung; Hung, Peir-Haur; Tsai, Hung-Bin; Liu, Chun-Jen; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; 劉振驊; 高嘉宏; 蘇東弘; 劉俊人; 陳培哲 |
| 國立臺灣大學 |
2012 |
Synthesis and biological activity of obatoclax derivatives as novel and potent SHP-1 agonists
|
Su, Jung-Chen; Chen, Kuen-Feng; Chen, Wei-Lin; Liu, Chun-Yu; Huang, Jui-Wen; Tai, Wei-Tien; Chen, Pei-Jer; Kim, Inki; Shiau, Chung-Wai; 陳昆鋒; 陳培哲 |
| 國立臺灣大學 |
2012 |
A phase I/II study of foretinib, an oral multikinase inhibitor targeting MET, RON, AXL, TIE-2, and VEGFR in advanced hepatocellular carcinoma (HCC).
|
Yau, Thomas Cheung; Sukeepaisarnjaroen, Wattana; Chao, Yee; Yen, Chia-Jui; Lausoontornsiri, Wirote; Chen, Pei-Jer; Sanpajit, Theeranun; Lencioni, Riccardo; Camp, Aaron C.; Cox, Donna S.; Kallender, Howard; Ottesen, Lone Harild; Poon, Ronnie Tung-Ping; 陳培哲 |
| 臺大學術典藏 |
2012 |
High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load
|
Tseng, T.-C. and Liu, C.-J. and Yang, H.-C. and Su, T.-H. and Wang, C.-C. and Chen, C.-L. and Kuo, S.F.-T. and Liu, C.-H. and Chen, P.-J. and Chen, D.-S. and Kao, J.-H.; Tseng, Tai-Chung;Liu, Chun-Jen;Yang, Hung-Chih;Su, Tung-Hung;Wang, Chia-Chi;Chen, Chi-Ling;Kuo, Stephanie Fang-Tzu;Liu, Chen-Hua;Chen, Pei-Jer;Chen, Ding-Shinn;Kao, Jia-Horng; 陳定信 ;劉振驊 ;高嘉宏 ;楊宏志 ;劉俊人 ;陳培哲 ;陳祈玲; HUNG-CHIH YANG; Tseng, Tai-Chung; Tseng, Tai-Chung; Liu, Chun-Jen; CHUN-JEN LIU; Liu, Chun-Jen; Yang, Hung-Chih; PEI-JER CHEN; Yang, Hung-Chih; CHEN-HUA LIU; Su, Tung-Hung; Su, Tung-Hung; TUNG-HUNG SU; Wang, Chia-Chi; Wang, Chia-Chi; DING-SHINN CHEN; Chen, Chi-Ling; JIA-HORNG KAO; Kuo, Stephanie Fang-Tzu; Liu, Chen-Hua; Liu, Chen-Hua; Chen, Pei-Jer; Chen, Pei-Jer; Chen, Ding-Shinn; Chen, Ding-Shinn; Kao, Jia-Horng; Kao, Jia-Horng |
| 高雄醫學大學 |
2011 |
A randomised phase II study of pegylated arginine deiminase (ADI-PEG 20) in Asian advanced hepatocellular carcinoma patients.
|
盧勝男;趙毅;王蒼恩;陳信成;彭康嘉康;陳培哲;陳立宗 ; Yang TS;Lu SN;Chao Y;Sheen IS;Lin CC;Wang TE;Chen SC;Wang JH;Liao LY;Thomson JA;Wang-Peng J;Chen PJ;Chen LT. |
| 高雄醫學大學 |
2011 |
Long-term effect of interferon plus ribavirin on hepatitis B surface antigen seroclearance in patients dually infected with hepatitis B and C viruses.
|
葉明倫;黃志富;劉俊人;李詮謀;戴嘉言;王景弘;林子堯;盧勝男;胡崇輝;余明隆;高嘉宏;莊萬龍;陳培哲;陳定信 ; Yeh ML;Hung CH;Huang JF;Liu CJ;Lee CM;Dai CY;Wang JH;Lin ZY;Lu SN;Hu TH;Yu ML;Kao JH;Chuang WL;Chen PJ;Chen DS. |
| 高雄醫學大學 |
2011 |
Effect of host and viral factors on hepatitis B e antigen-positive chronic hepatitis B patients receiving
|
曾岱宗;余明隆;劉俊人;林志陵;許景盛;劉振樺;楊賢馨;蘇建維;陳培哲;陳定信;高嘉宏. ; Tseng TC;Yu ML;Liu CJ;Lin CL;Huang YW;Hsu CS;Liu CH;Kuo SF;Pan CJ;Yang SS;Su CW;Chen PJ;Chen DS;Kao JH. |
| 國立臺灣大學 |
2011 |
Signal transducer and activator of transcription 3 is a major kinase- independent target of sorafenib in hepatocellular carcinoma=STAT3為 Sorafenib於肝癌的主要標的
|
戴瑋恬; 鄭安理; 蕭崇瑋; 黃祥博; 黃瑞雯; 陳培哲; TAI, WEI-TIEN; CHENG, ANN-LII; SHIAU, CHUNG-WAI; HUANG, HSIANG-PO; HUANG, JUI-WEN; CHEN, PEI-JER; CHEN, KUEN-FENG |
| 國立臺灣大學 |
2011 |
Final Results of Enable 1, a Phase 3, Multicenter Study of Eltrombopag as an Adjunct for Antiviral Treatment of Hepatitis C Virus-Related Chronic Liver Disease Associated with Thrombocytopenia
|
陳培哲; CHEN, PEI-JER |
| 國立臺灣大學 |
2011 |
Hepatitis B Virus: Genotypic and Virological Resistance
|
陳培哲; CHEN, PEI-JER |
| 國立臺灣大學 |
2011 |
Depletion of Beta-Catenin from Mature Hepatocytes of Mice Promotes Expansion of Hepatic Progenitor Cells and Tumor Development
|
王爾雅; 葉秀慧; 蔡亭芬; 黃祥博; 鄭永銘; 林煒翔; 陳韋志; 葉坤輝; 陳培哲; 陳定信; WANG, ER-YEA; YEH, SHIOU-HWEI; TSAI, TING-FEN; HUANG, HSIANG-PO; JENG, YUNG-MING; LIN, WEI-HSIANG; CHEN, WEI-CHIH; YEH, KUN-HUEI; CHEN, PEI-JER; CHEN, DING-SHINN |
顯示項目 176-200 / 526 (共22頁)
<< < 3 4 5 6 7 8 9 10 11 12 > >>
每頁顯示[10|25|50]項目
|
